6CIBIS-Ⅱ Investigators and Committees.The Cardiac Insufficiency Bisoprolol StudyⅡ(CIBIS-Ⅱ):A randomized trial[J].Lancet,1999,353:2001-2006.
7Hjalmarson FG.Effects of controlled-release metoprolol on total mortality,hospitalization,and well-being in patients with hear failure,The Metoprolol CR/XLR and omized international Trial in Congestive Heart Failure(MERLT-HF)[J].JAMA,2000,283:295-302.
8Cesari M,Rossi GP,Pessina AC.Biological properties of the angiotensin peptides other than angiotentin Ⅱ:Implications for hypertension and cardiovascular diseases[J].J Hypertens,2002,20(5):799.
9Horiuchi M,Akishita M,Dzau VJ.Recent progress in angiotensin Ⅱtype receptor research in the cardiovascular system[J].Hypertension,1999,33(2):613-621.
10Levy BL.Can angiutensin Ⅱ type 2 receptors have deleterious effects in cardiovascular disease? Implication for therapeutic blockade of the renin-angiotentin system[J].Circulation,2004,109(1):8-13.
